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Bacterial infections and antibiotic resistance, particularly by Gram-negative pathogens, have
become a global healthcare crisis. We report the design of a class of cationic antimicrobial
polymers that cluster local facial amphiphilicity from repeating units to enhance interactions
with bacterial membranes without requiring a globally conformational arrangement associated with highly unfavorable entropic loss. This concept of macromolecular architectures
is demonstrated with a series of multicyclic natural product-based cationic polymers. We
have shown that cholic acid derivatives with three charged head groups are more potent and
selective than lithocholic and deoxycholic counterparts, particularly against Gram-negative
bacteria. This is ascribed to the formation of true facial amphiphilicity with hydrophilic ion
groups oriented on one face and hydrophobic multicyclic hydrocarbon structures on the
opposite face. Such local facial amphiphilicity is clustered via a ﬂexible macromolecular
backbone in a concerted way when in contact with bacterial membranes.
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A

ntimicrobial resistance is an ever-increasing threat to
public health, and is projected to be accountable for more
deaths than cancer and AIDS combined by 20501,2. The
effective treatments for bacterial infections are becoming radically
diminished as bacteria develop resistance against most available
antibiotics3. Among these multidrug-resistant (MDR) pathogens,
Gram-negative bacteria pose more perilous threats to human
life4. Most infections caused by Gram-negative MDR bacteria are
essentially untreatable, and may lead to severe illness or even
death4,5. Despite this fact, the development of new antimicrobial
therapies has been primarily focused on Gram-positive
bacteria6,7. The presence of dual membranes in Gram-negative
bacteria acts as an impermeable barrier to most antibiotics. As a
result, there arises an urgent need for new-generation antimicrobials with potent therapeutic activity, novel modes of
action, and without driving the current increase of antimicrobial
resistance, especially to combat the growing epidemic of infections caused by MDR pathogens.
Natural antimicrobial peptides (AMPs) are amphiphilic,
combining cationic charges and hydrophobic components, and
able to electrostatically bind to anionic bacterial membranes
or other anionic targets8–13. It is well known that in many
cases, AMPs form an α-helix structure with positive charges
arrayed on one side and lipophilic groups aligned along the
other side in contact with bacterial membranes (Fig. 1a)14–16.
The common structural features of these AMPs with a global
segregation of cationic and lipophilic side chains are also referred
to as facial amphiphilicity (i.e. separate hydrophilic and

hydrophobic faces)16,17. Facial amphiphilicity allows AMPs to
efﬁciently insert into bacterial membranes via the barrel-stave
pore, toroidal pore, disordered toroidal pore, and/or carpet
mechanisms, leading to cytoplasmic leakage, membrane depolarization, lysis, and cell death18,19. Over the last two decades,
natural AMP-mimicking peptide derivatives such as β-peptides
and peptoids have been developed with potent antimicrobial
activity20–23. However, the clinical applications of AMPs are
very limited due to their low bioavailability, low stability, high
manufacturing cost, as well as in many cases nonspeciﬁc toxicity
to mammalian cells7,13,19,24. To address these issues, synthetic
polymers with cationic charges, which mimic natural AMPs
and selectively attack negative bacterial cell membranes over
zwitterionic mammalian cell membranes, have been studied
widely as a promising solution to combat bacteria. These polymers offer a broad spectrum of antimicrobial activity, a membrane disruption mechanism as well as a low propensity for
developing resistance13,18,25,26. In addition, cationic chargecontaining polymers can be obtained in large quantities at
much lower cost. Many antimicrobial polymers are highly effective in killing traditional strains. We have developed several
antimicrobial macromolecules utilizing bulky hydrophobic
structures containing natural resin acids and antibiotic-metal
bioconjugates that exhibit excellent activities against bacteria,
particularly against Gram-positive bacteria such as methicillinresistant Staphylococcus aureus (MRSA), while simultaneously
exhibiting low hemolysis against red blood cells and minimal
in vitro and in vivo cytotoxicity27–35.
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Fig. 1 Modes of action adopted upon approaching to a biomembrane surface. a Host-defense peptides adopting a globally amphiphilic helical
conformation36; b Synthetic antimicrobial polymers adopting a globally amphiphilic conformation; and c A ﬂexible macromolecular chain clustering intrinsic
local facial amphiphiles (this work). Red color: cationic/hydrophilic groups, yellow color: hydrophobic groups
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Fig. 2 Design principle of cationic polymers with an intrinsic facial amphiphilic structure at repeat units. The key building block should have a multicyclic
structure with the possibility for derivatization to possess one face hydrophilic and the other face hydrophobic. Cholic acid is illustrated as an example here

However, most antimicrobial polymers with AMP-mimicking
designs are based on the adoption of a conformation that
is globally amphiphilic, which requires control on the
sequence of hydrophobic and hydrophilic subunits. Gellman
and coworkers stated that the facial amphiphilicity could be
achieved from random copolymerization of hydrophobic and
hydrophilic monomers that did not require control of subunit
sequences16,36,37. Their copolymers contained both cationic and
lipophilic groups as well as sufﬁciently ﬂexible backbones that
could form a globally amphiphilic, but conformationally irregular
helical structure induced by negatively charged bacterial membranes (Fig. 1b). DeGrado, Kuroda and coworkers also synthesized methacrylate-based copolymers consisting of ﬂexible
backbones and amphiphilic compositions with low toxicity and
good antimicrobial activity38,39. Tew et al. synthesized amphiphilic cationic polymers that also exhibited good antimicrobial
activity, where they used amphiphilic monomers (i.e., containing
both a hydrophilic ammonium and a hydrophobic norbornene
on the same polymerizable unit)40,41.
However, most of these approaches rely on uncontrolled
polymeric self-aggregation to achieve global facial amphiphilicity,
which is difﬁcult to manipulate. From the perspective of free
energy change upon the contact with bacterial cell membranes,
the fact of adopting a facial amphiphilic conformation without
the helical structures from random coil structures of synthetic
polymers would suffer a very high entropic penalty from a whole
macromolecule (Fig. 1b).
In fact, most antimicrobial polymers do not comprise truly
facial amphiphilicity and suffer poor selectivity and high cytotoxicity against mammalian cells and are also ineffective against
MDR Gram-negative bacteria. We hypothesized that a ﬂexible
macromolecule carrying intrinsic facial amphiphilic units with a
large cross-sectional area would offer a novel type of antimicrobial polymer, in which each local unit could exert an
insertable handle upon contact with bacterial membranes.
The polymeric backbone not only avoids adopting a highly
energetic, global amphiphilicity, but also assembles the intrinsic
local facial amphiphilic structures on cell membranes. The
macromolecular structures would signiﬁcantly increase the
density of local facial amphiphilicity and thus enhance
the overall interactions with bacterial cells. To test this hypothesis, we chose multicyclic natural products, e.g. steroid acids or
terpenoids, as a functionalized building block to possess local
facial amphiphilicity.
Bile acids are cholesterol-derived amphiphilic steroid acids
produced in mammals and other vertebrates. They have been
utilized in many areas including drug delivery, sensors, polymeric
gels, antimicrobials, and other biological applications35,42–44.
There are four different derivatives of bile acids, which vary by
the number of hydroxyl groups, such as cholic acid (CA),

deoxycholic acid (DCA), chenodeoxycholic acid, and lithocholic
acid (LCA) (Supplementary Figure 1a). Hydroxyl groups of bile
acid molecules are positioned in the concave α-face while the
multicyclic hydrocarbon structure is constituted as the convex
β-face, thereby providing the potential to achieve true facial
amphiphilicity (Fig. 2). The steroidal nucleus with four fused
rings provides a hydrophobic core with a signiﬁcantly larger
cross-sectional area compared to linear alkyl chains. The facial
amphiphilicity, biocompatibility, and hydrophobicity of bile
acid derivatives are considered highly favorable for interactions
with bacterial cell membranes.
Herein we report the synthesis of cationic bile acid-based
polymers that possess intrinsic local facial amphiphilicity
clustered together via a ﬂexible macromolecular chain (Fig. 2).
The presence of hydroxyl groups from the α-face allows the
installation of cationic quaternary ammonium charges (QAC)
as hydrophilic components. The carboxylic acid at the edge of
this particular structure offers chemical functionalization for
the attachment as a pendant monomeric unit integrated into a
ﬂexible macromolecular skeleton. Three different bile acid derivatives, lithocholic, deoxycholic, and cholic acid are constructed
with one, two, and three QAC respectively, as cationic head
groups via the hydroxyl functionality. This provides a unique
avenue for tuning amphiphilicity and testing the level of facial
amphiphilicity.
Results
Synthesis of cationic multicyclic natural product-derived
polymers. A class of cationic polymers was synthesized from
bile acid derivatives in four steps. Methacrylate monomers of
cholic acid, (2-methacryloyloxy)ethyl cholate (MAECA), deoxycholic acid, (2-methacryloyloxy)ethyl deoxycholate (MAEDA),
and lithocholic acid, (2-methacryloyloxy)ethyl lithocholate
(MAELA) were synthesized by simple esteriﬁcation coupling
reactions of respective bile acid and hydroxyethyl methacrylate
(HEMA) at room temperature45. The reaction scheme in Fig. 3
illustrates the synthesis using cholic acid as an example. Each
monomer of MAECA, MAEDA, and MAELA was then polymerized via reversible addition-fragmentation chain transfer
(RAFT) polymerization utilizing 4-cyano-4-(thiobenzylthio)pentanoic acid as a chain transfer agent. Molecular weight of all
three bile acid-containing polymers was controlled with low
dispersity as determined by Gel Permeation Chromatography
(GPC) (Supplementary Table 1). Hydroxyl groups of these
homopolymers were further modiﬁed through an esteriﬁcation
reaction with bromoalkanoyl chloride. After post modiﬁcation,
the peaks next to the alcohol group in 1H NMR at ~ 3.2–3.8 ppm
shifted to 4.7–5.2 ppm (Supplementary Figure 2a). The methylene
group next to the bromine group appears at ~3.4–3.6 ppm,
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Fig. 4 Multicyclic natural product-based cationic polymer structures and their illustration. a, d CA polymer, b, e DCA polymer, c, f LCA polymer

indicating the formation of an ester linkage. The disappearance
of a broad peak at 3500–3600 cm−1 corresponding to hydroxyl
groups and appearance of a higher intensity peak at 1720 cm−1 in
FTIR spectra (Supplementary Figure 2b) for the ester group
further conﬁrmed the post-polymerization modiﬁcation of
hydroxyl groups in homopolymers. Evidence of successful postpolymerization modiﬁcation was also established by the slight
shift of GPC traces of polymers before and after modiﬁcation
(Supplementary Figure 2c). Finally, the bromine groups were
substituted by trimethylamine to offer quaternary ammoniumcontaining polymers. The appearance of an intense peak at ~3.0
ppm for three methyl and one methylene group in 1H NMR
spectra conﬁrmed the formation of quaternary ammoniumcontaining polymers (Supplementary Figure 2a). Finally, cationic
homopolymers with single, double, and triple QAC head groups
4

were obtained from lithocholic acid, deoxycholic acid, and cholic
acid respectively (Fig. 4).
Cholic acid-based cationic polymers having a series of
molecular weight were further prepared to study the effect of
molecular weight on antimicrobial activity (Supplementary
Table 1). The spacer length of methylene (one, three, and ﬁve)
between QAC and the ester group was also investigated in order
to examine its effect on antimicrobial efﬁcacy, for which polymers
with similar molecular weight were used for post-polymerization
modiﬁcation. Polymers were denoted according to their respective derivative resource, molecular weight, and spacer unit (i.e.
CA_19k_5 is a cholic acid polymer with molecular weight of
19,000 g mol−1 and a spacer of ﬁve methylene). To compare the
antimicrobial activity with polymers, a three QAC-containing
cholic acid-based monomer (labeled as CA_Monomer) was also
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Table 1 Antimicrobial activity of different multicyclic natural product-based cationic polymers by a broth microdilution method
Polymers

Minimum inhibitory concentration (MIC)a (µg mL−1)

HC50
(µg mL−1)

S. aureus
E. coli
P. aeruginosa
E. coli
(ATCC(ATCC(ATCC(ATCC33591)
BAA-197)
10145)
11775)
CA_19k_5
11.2
3.1
11.5
19.1
>306
DCA_19k_5
11.5
6.4
20.4
24.6
>37
LCA_20k_5
11.4
3.4
20.5
56.8
NT
Effect of the spacer length on antimicrobial activity of cholic acid-based cationic polymers
CA_19k_5
11.2
3.1
11.5
19.1
>306
CA_19k_3
12.5
10.4
12.4
19.6
>31
CA_19k_1
25.6
22.2
37.7
45.6
>8
Effect of molecular weight on antimicrobial activity of cholic acid-based cationic polymers
CA_10k_5
6.4
3.0
6.8
15.3
>110
CA_19k_5
11.2
3.1
11.5
19.1
>306
CA_25k_5
11.4
10.5
11.9
19.1
>315
CA_32k_5
12.2
19.4
14.5
27.4
>1886
CA_Monomer
22.3
12.8
22.5
25.6
NT

Selectivity
of E. coli
(ATCC-11775)
(HC50/MIC)

Selectivity of
P. aeruginosa
(ATCC-10145)
(HC50/MIC)

Selectivity of E.
coli (ATCC-BAA197) (HC50/MIC)

>27
>3
NT

>98
>5
NT

>26
1
NT

>27
>2
NT

>98
3
NT

>26
2
NT

>17
>27
>28
>154
NT

>37
>98
>30
>97
NT

>16
>26
>26
130
NT

NT not tested
aMIC is the lowest polymer concentration that completely inhibits bacterial growth

prepared, shown in Supplementary Figure 1b. The experimental
details are given in the Methods and Supplementary Information.
Antimicrobial activities. The antimicrobial activities of multicyclic natural product-based cationic polymers were evaluated
against clinically relevant Gram-positive bacteria S. aureus and
Gram-negative bacteria E. coli and P. aeruginosa. Initially, the
antimicrobial activity of three different bile acid polymers with a
spacer of ﬁve methylene and molecular weight ~19,000 g mol−1
was evaluated by standard agar disc diffusion assay. The observation of clear inhibition zones indicated that all three polymers
have potent activity against both Gram-negative and Grampositive bacteria at different levels. Among them cholic acid
polymers are the most effective, and lithocholic acid ones are the
least (Supplementary Figure 8). Interestingly, the initial studies
also revealed that all these polymers had higher efﬁcacies towards
Gram-negative bacteria than Gram-positive pathogens.
We then determined the minimum inhibitory concentration
(MIC) of polymers by a broth microdilution method and
compared the killing efﬁciency of each bile acid polymer. The
MIC results (Table 1) demonstrated that the cholic acid-based
polymer (CA_19k_5) exhibited more potent antimicrobial
activity, with signiﬁcantly lower MICs in comparison to
deoxycholic acid (DCA_19k_5) and lithocholic acid
(LCA_20k_5) based polymers. A delicate balance of hydrophobicity and hydrophilicity is one of the essential factors for
selective interactions with bacterial membranes. Since all bile
acid-based cationic polymers contain the same hydrophobic four
fused rings in each repeating unit, the change in hydrophilicity is
critical for the antimicrobial activities. The cholic acid-based
polymer contains three QAC groups in each repeating unit,
making it more hydrophilic with higher charge densities, whereas
deoxycholic acid and lithocholic acid are less hydrophilic because
of fewer charged groups. Consequently, deoxycholic acidcontaining polymer DCA_19k_5 exhibited moderate sensitivity
towards bacteria while LCA_20k_5 is least effective towards
bacteria. Our results demonstrated that the higher charge
densities of a polymer could lead to more signiﬁcant interactions
with bacterial membranes, similar to observations made by Yang
and colleagues46,47. Though all polymers can inhibit bacterial
growth, they again exhibited enhanced potency towards Gramnegative bacteria. For example, the MICs of CA_19k_5 are 11.2

and 3.1 μg mL−1 against E. coli and P. aeruginosa respectively,
whereas about 19.1 μg mL−1 against S. aureus. This is signiﬁcant
as there are few antibiotics available for the treatment of
infections by Gram-negative bacteria, in particular, pathogenic
P. aeruginosa.
We further studied the effect of methylene spacers in cholic
acid-based polymers on antimicrobial activity (Fig. 5). We
observed that polymers containing a longer spacer showed more
potent killing efﬁcacy compared to those with shorter spacers. As
shown in Table 1, CA_19k_5 polymer (5 methylene units
separated from the cationic charge) exhibited higher antimicrobial activity against both Gram-positive and Gram-negative
bacteria than CA_19k_3 and CA_19k_1. According to the
snorkeling effect in peptides48–50, a longer spacer unit could
provide increased hydrophobicity, and the additional distance
between the QAC groups and the hydrophobic multicyclic ring
attached to the polymer backbone would facilitate a deeper
insertion of the polymer chain into the bacterial membrane. In
contrast, a shorter spacer has less ﬂexibility and room for
extending the charge group through the membrane51. A longer
spacer could not only facilitate the charge group easier to reach a
target substrate (here cell membrane), but provide a ﬂexible
anchoring on surfaces without requiring a conﬁgurational change
of the bulky triterpene structure.
Next, we explored the effect of molecular weight (Mn) of
polymers on the antimicrobial activity (Table 1). In case of P.
aeruginosa, the MICs of higher molecular weight polymers
increased. For E. coli, the molecular weight at the test range has a
minimal effect on the activity. In case of Gram-positive bacteria,
S. aureus, the lower molecular weight polymer CA_10k_5
exhibited a MIC of ~ 15.3 μg mL−1, whereas the MIC for
CA_32k_5 was at 27.4 μg mL−1. These results indicated that
CA polymer with ~10,000 g mol−1 molecular weight exhibited
better efﬁcacy than the higher molecular weight polymers. This
could be explained by the potential trapping of higher molecular
weight polymers in the dense, outmost peptidoglycan layer of S.
aureus. This observation is consistent with the sieving effect, as
also identiﬁed by Lienkamp et al52. We also evaluated the
antimicrobial activity of a cationic cholic acid based monomer
(CA_Monomer, Table 1), which is lower than that of polymers.
This might be due to the increase of the density of local facial
amphiphilicity from polycations than monomers, which was
similarly observed by many other groups on different systems53.
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Fig. 6 Drug resistance study of CA_19k_5 against P. aeruginosa and E. coli upon multiple sublethal dose treatment. The Data are collected from the three
replicates and the error bars represent the s.d. of three replicates

Antimicrobial activity was further investigated using a
clinically isolated MDR strain of E. coli (ATCC-BAA-197). As
shown in Table 1, all cholic acid polymers containing a ﬁvemethylene spacer inhibited the growth of this strain, and with low
MIC values (7–15 μg mL−1), demonstrating a high efﬁcacy
against MDR E. coli. These MIC values increased with polymers
containing the shorter spacer unit. However, the MIC values are
comparatively higher than those for regular strains of E. coli
(ATCC-11775), which is possibly due to varying phospholipid
compositions. It is worth noting that the cholic acid polymers
with a molecular weight in the range of 10,000–20,000 g mol−1 is
also more efﬁcient at inhibiting bacterial growth than those with
higher molecular weight.
To evaluate the possible bacterial resistance of cholic acidbased polymers, we performed an antimicrobial resistance study
for one of the most potent polymers, CA_19k_5, against P.
aeruginosa and E. coli. Bacteria were exposed multiple times to
the polymer at a sub-MIC level, and the MIC was measured for
every consecutive passage. Detailed experimental procedures are
provided in the supplementary information. After 10 passages, no
signiﬁcant changes in the MIC values were observed, as detailed
in Fig. 6. This important result demonstrated that developing
resistance against cholic acid-based cationic polymers is inherently difﬁcult for both P. aeruginosa and E.coli bacterial strains.
Hemolytic activities. The toxicity of bile acid-derived cationic
polymers was evaluated by measuring hemoglobin release from
mouse red blood cells (RBCs) at various concentrations. The
selectivity for bacterial cells over mammalian cells was determined by the ratio of HC50 (the concentration of a polymer that
causes 50% hemolysis of RBCs) to MIC values (HC50/MIC). As
mentioned previously, the hydrophobic and hydrophilic balance
of an antimicrobial polymer plays a critical role for the selective
attachment to a bacterial cell membrane. It is well established that
a polymer with higher hydrophobicity or lower hydrophilicity
produces hemolysis to a greater extent, due to the strong
6

interaction with the lipid portion of a mammalian cell
membrane25,47,54. As shown in Table 1, all cholic acid polymers
exhibited negligible hemolysis at their respective MIC values,
demonstrating excellent selectivity toward a broad range of
pathogenic microbes over mammalian cells.
Bile acid derivatives are intrinsically hydrophobic due to the
presence of a four fused-ring structure. All cholic acid polymers
contain three positive head groups in each repeat unit, which
reduces hydrophobicity. In contrast, the deoxycholic acid-based
polymer possesses only two positive charged head groups in each
repeat unit, making it more hydrophobic with a substantial level
of toxicity. The hemolysis activity of lithocholic acid-based
cationic polymers was not determined due to poor solubility in
water. Additionally, the molecular weight of polymers was also
found to have some effect on hemolysis activity (Table 1). We
observed that HC50 increased with the increase of molecular
weight of cholic acid-based polymers. The length of spacers also
has an enormous impact on hemolysis, as shown in Table 1. We
observed that the cholic acid polymers containing shorter spacers
(CA_19k_1 and CA_19k_3) are more toxic compared to the
longer spacer containing polymer (CA_19k_5). There are many
parameters to inﬂuence the hemolytic activity, especially the
balance of hydrophilicity and hydrophobicity. The low HC50
value for CA_19k_1 might be related with insufﬁcient electrostatic interactions due to the short spacer linking cationic charges,
which could amplify the hydrophobic effect by cholic acid on the
more hydrophobic nature of membranes from mammalian cells.
Mechanisms of action. To elucidate the mode of action of bile
acid-derived polymers against bacteria, we performed confocal
laser scanning microscopy (CLSM) to investigate the membrane
permeability changes before and after treatment with CA_19k_5
polymer using a LIVE/DEAD BacLight assay kit. The concentration of polymers is two times that of the MIC value. As
shown in Fig. 7, green colored cells were observed for control
bacteria (E. coli and P. aeruginosa), revealing most cells live with
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CLSM
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P. aeruginosa
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Fig. 7 CLSM and SEM images of E. coli and P. aeruginosa under control and CA_19k_5 treatment with two times of MIC concentration. Bacteria
concentrations were 1.0 × 106 CFU/mL. Bacterial solutions without CA_19k_5 were used as the control. Scale bar in confocal images is 25 µm and scale bar
in SEM images is 2 µm

intact bacterial membranes. In contrast, when the bacteria were
treated with polymer CA_19k_5, most cells were killed. These
ﬁndings revealed that the antimicrobial activity of bile acid-based
cationic polymers occurred by the disruption of bacterial membrane, consistent with the membrane lytic mechanism of various
synthetic antimicrobial polymers28,39,46,55. In case of S. aureus,
these polymers are less effective (Supplementary Figure 9). The
antimicrobial mechanism of action was further investigated
through the observation of morphological changes of bacterial
cells after CA_19k_5 polymer treatment using scanning electron
microscopy (SEM). Bacteria E. coli and P. aeruginosa under
control remained intact with smooth surfaces as shown in Fig. 7,
whereas polymer-treated cells were signiﬁcantly damaged and
highly distorted from the original morphology. Most bacterial
cells were shown to be signiﬁcantly fragmented. The signiﬁcant
physical damage of cell membranes was observed for S. aureus
only when the concentration of polymers was increased to four
times that of the MIC value (Supplementary Figure 10). The loss
of original morphology with cell membrane damage was more
apparent in the case of Gram-negative bacteria compared to that
of Gram-positive bacteria.
Discussion
Bile acid derivatives (mostly small molecules) have been developed as antimicrobial agents. Moore et al.56 reported that cationic
bile salts share some structural features with an antibiotic squalamine isolated from sharks. Diamond et al. prepared a family of
head-to-tail cationic lipids that combine cholic acid and spermine, which showed enhanced antimicrobial activity related to
increased hydrophobicity, although no facial amphiphilicity was
explored57. Savage and co-workers claimed that membrane-active
facial amphiphilic cationic molecules, such as bile acid derivatives, could disrupt bacterial membranes58,59. Cholic acid-derived
cationic surfactants can form micellar structures that exhibit
antimicrobial activity against Gram-positive and Gram-negative
bacteria60. However, higher susceptibility to the resistance of
these small molecules remains a signiﬁcant issue.
In the current study, we developed a class of antimicrobial
polymers from bile acids, which possess macromolecular conformations critical for interactions with bacterial membranes. We

observed that cholic acid-based cationic polymers are more
effective against Gram-negative bacteria, especially P. aeruginosa,
than Gram-positive bacteria (e.g. S. aureus). Different from
Gram-positive bacteria using peptidoglycan as the major periphery enveloping their cell membranes, Gram-negative bacteria
possess double membranes with the outer membrane made up of
zwitterionic phosphatidylethanolamine (PE) and other anionic
phospholipids as their periphery for self-defense. Therefore, in
Gram-negative bacteria it is more challenging for antimicrobial
agents to balance their hydrophobicity and cationic charges as
well as to adopt a conformation that is favorable for interactions
with the outer membrane.
The hydrophobic multicyclic structure and three oriented
cationic charges in the modiﬁed cholic acid provide true facial
amphiphilicity in contact with bacterial cell membranes. Initially,
three cationic charges on each cholic acid unit localize onto the
outer membrane as a result of electrostatic interactions (Fig. 8),
then the hydrophobic face of cholic acid inserts into the membrane. Since each of this unique moiety is attached to a ﬂexible
macromolecular chain, collectively tens of (or even hundreds of)
these local facial amphiphilic structures would facilitate each
other and promote the entire macromolecule to penetrate
through the membrane (Fig. 8). Such a concerted penetration of
macromolecular chains across the cell membrane would cause its
destabilization and fragmentation, ultimately leading to cell
death. With this design, there is no need for an entire macromolecule to adopt a globally entropy-unfavorable facial amphiphilic conformation. Conversely, Gram-positive bacteria, like S.
aureus, have membranes primarily composed of anionic lipids
such as phosphatidylglycerol (PG) and cardiolipin (CL), which is
overlain by a dense and thick peptidoglycan layer46. Bulky cholic
acid-based polymers could be more easily trapped in this layer
and thus less effective in disrupting these cell membranes.
In summary, we reported a design of antimicrobial polymers
with repeat units possessing local facial amphiphilicity, which
could promote effective interactions of an entire macromolecule
with bacterial cell membranes, circumventing the adoption of an
energetically unfavorable global facial amphiphilicity. Speciﬁcally,
we derivatized three different multicyclic natural products.
Among them, cholic acid polymers were shown to be more efﬁcient than their deoxycholic and lithocholic acid counterparts,
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Fig. 8 A proposed mechanism of action of cholic acid-based polymers on the bacterial cell membrane: 1 diffusion, 2 surface binding, 3 membrane insertion
and 4 membrane disruption. The illustrated cholic acid can be replaced by other multicyclic compounds that are modiﬁed with facial amphiphilicity

regarding both antimicrobial activity and selectivity. This is
ascribed to the true facial amphiphilic structure from cholic acid
derivatives, which have the hydrophobic multicyclic structure as
one face and three oriented hydrophilic cationic charges as the
other face. It is worth noting that a lot of multicyclic natural and
synthetic compounds could be used as the key building block.
This macromolecular structure and conformation may open an
avenue toward next-generation antimicrobial agents to treat
multidrug-resistant Gram-negative bacteria.
Methods
Synthesis of monomers. (2-methacryloyloxy)ethyl cholate (MAECA) monomer
was synthesized via an esteriﬁcation reaction between CA and 2-hydroxyethyl
methacrylate (HEMA) in the presence of 1-(3-dimethylaminopropyl)-3-ethyl carbodiimide hydrochloride (EDC·HCL) and 4-dimethylamino pyridine (DMAP).
Initially, CA (5.0 g, 12.24 mmol) and DMAP (0.16 g, 1.35 mmol) were dissolved in
40 mL of dry tetrahydrofuran (THF) under nitrogen. EDC·HCl (2.58 g, 13.46
mmol) was added to the solution. After placing the reaction mixture in an ice bath,
HEMA (1.75 g, 13.56 mmol) was added dropwise to the solution and then progressed for 48 h at room temperature. The reaction mixture was ﬁltered and evaporated. The crude product was redissolved in dichloromethane (DCM) (60 mL)
and washed with 5% HCl solution (25 mL × 1), saturated NaHCO3 (25 mL × 3),
water (25 mL × 2), and brine solution (25 mL × 2). After drying the organic layer
over anhydrous MgSO4, the solvent was removed by rotary evaporation. Silica
column chromatography with hexane: ethyl acetate (7: 3) as eluents was carried out
to yield a product with a yield of 60%. 1H NMR (Supplementary Figure 2a)
(300 MHz, CDCl3, δ, ppm): 6.13 and 5.59 (2 H, s, a), 4.33 (4 H, m, b & b’), 3.96 (1
H, t, c), 3.84 (1 H, q, d), 3.45 (1 H, m, e), 1.94 (3 H, s, f), 0.97 (3 H, d, g), 0.88 (3 H,
s, h), and 0.67 (3 H, s, i). ES-MS (Supplementary Figure 11): observed m/z for
[M + Na+] 543 and [M + H+] 521.
(2-methacryloyloxy)ethyl deoxycholate (MAEDA) was synthesized according to
a similar procedure to the synthesis of MAECA. 1H NMR (Supplementary
Figure 3a) (300 MHz, CDCl3, δ, ppm): 6.13 and 5.59 (2 H, s, a), 4.33 (4 H, m, b &
b’), 3.97 (1 H, t, c), 3.61 (1 H, m, d), 1.94 (3 H, s, e), 0.97 (3 H, d, f), 0.88 (3 H, s, h),
and 0.67 (3 H, s, g). ES-MS (Supplementary Figure 12): observed m/z for [M +
Na+] 527 and [M + H+] 505.
(2-methacryloyloxy)ethyl lithocholate (MAELA) was also synthesized according
to a similar procedure to the synthesis of MAECA, except for the puriﬁcation
process. Silica column chromatography with hexane: ethyl acetate (3: 2) as eluents
was carried out to yield a product with a yield of 50%. 1H NMR (Supplementary
Figure 3b) (300 MHz, CDCl3, δ, ppm): 6.12 and 5.59 (2 H, s, a), 4.33 (4 H, m, b & b′),
3.61 (1 H, m, c), 1.94 (3 H, s, d), and 0.62 (3 H, s, e). Direct-probe mass spectrum
(Supplementary Figure 13): observed m/z 488.
Synthesis of bile acid polymers. Methacrylate monomers were polymerized using
a typical RAFT polymerization technique45. For example, MAECA (0.70 g, 1.35
mmol), 4-Cyano-4-(thiobenzylthio)pentanoic acid (CTP) (6.27 mg, 0.0224 mmol),
8

and azobisisobutyronitrile (AIBN) (0.74 mg, 4.487 µmol) were placed in a 10 mL
Schlenk ﬂask and dissolved in N, N-dimethylformamide (DMF) (2 mL). The
mixture was performed with three freeze-pump-thaw cycles protected under
nitrogen and immersed into a preheated oil bath set at 70 °C. After a certain period
of time, the polymerization was quenched by exposure to air and cooled under an
ice water bath. The reaction mixture was precipitated twice into a mixture of
hexane and DCM (50:50) and ﬁnally dissolved in THF and precipitated into
hexane. The polymer was dried under vacuum.
Synthesis of bromoalkyl-containing bile acid polymers. CA polymer (300 mg)
was placed in a 25 mL round bottom ﬂask and dissolved in anhydrous DMF (3 mL).
Excess 6-bromohexanoyl chloride (3 mL) or 4-bromobutanoyl chloride (3 mL) or
bromoacetyl bromide (3 mL) was added to the polymer solution dropwise at room
temperature. The reaction mixture was allowed to stir at 55 °C for 48 h and precipitated into methanol. The product was redissolved in DCM (2 mL), precipitated
in methanol twice, and dried under vacuum. The reaction was conﬁrmed by 1H
NMR and FTIR. Similarly, DCA and LCA polymers were modiﬁed. 1H NMR
spectra of post-modiﬁed CA, DCA, and LCA polymer with 6-bromohexanoyl
chloride are shown in Supplementary Figures 2a, 3a, and b respectively. FTIR
spectra of modiﬁed CA, DCA, and LCA polymers with 6-bromohexanoyl chloride
are shown in Supplementary Figures 2b, 4a, b respectively. 1H NMR spectra of
modiﬁed CA polymer with 4-bromobutanoyl chloride and bromoacetyl bromide are
shown in the Supplementary Figure 5a, b respectively.
Synthesis of QAC-containing polymers. As an example: 6-bromohexyl-modiﬁed
CA polymer (300 mg) was dissolved in DMF (4 mL). Then, trimethylamine solution (33 wt%, 9 mL) in ethanol was added to the reaction mixture and stirred for
24 h at 55 °C. After cooling and concentrating the reaction mixture, the resulting
solution was precipitated in THF and centrifuged to collect the product. The
product was washed with THF and dried under vacuum. Finally, the product was
further puriﬁed by dialysis against DI water (1 L × 3) for 24 h. The solution in
dialysis bag was collected and freeze-dried to obtain a white product. DCA and
LCA polymers were similarly quaternized.
Synthesis of QAC-containing CA monomer. MAECA (0.50 g, 0.96 mmol), triethyl amine (2.91 g, 28.84 mmol), hydroquinone (0.19 mmol, 0.021 g), and catalytic
DMAP (0.035 g, 0.29 mmol) were dissolved in dry THF (10 mL) under nitrogen.
Then, 6-bromohexanoyl chloride (2.59 g, 14.42 mmol) was added dropwise to the
mixture at 0 °C was then stirred at room temperature for 36 h. The reaction
mixture was ﬁltered and evaporated. The residue was diluted with DCM and
washed with water (3 times), saturated NaHCO3 (3 times) and brine solution
(one time). The organic phase was dried over magnesium sulfate and concentrated,
then precipitated in hexane twice to remove unreacted 6-bromohexanoyl chloride.
The product was further puriﬁed by the silica column chromatography with
hexane: ethyl acetate (1: 4) as eluents to obtain a product with a yield of 55%.
The yellow product was dried under vacuum. The reaction was conﬁrmed by 1H
NMR (Supplementary Figure 6) and FTIR (Supplementary Figure 7). 1H NMR
(300 MHz, CDCl3, δ, ppm): 6.13 and 5.59 (2 H, s, e), 5.18 (1 H, t, a), 5.01
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(1 H, q, b), 4.53 (1 H, m, c), 4.29 (4 H, m, d & d′), 3.5 (6 H, t, g, g′& g′′), 2.48
(6 H, t, h, h′ & h′′), and 1.91 (3 H, s, f).
Compound 1 (200 mg, 0.19 mmol) (Supplementary Figure 1b) was dissolved in
DMF (3 mL). Then, trimethylamine solution (33 wt%, 10 mL) in ethanol was added
to the reaction mixture and stirred for 24 h in a closed reaction vessel at 55 °C.
After cooling and concentrating the reaction mixture, the resulting solution was
precipitated in THF and centrifuged to collect the product. The product was
further washed with THF and dried under vacuum. The reaction product was
conﬁrmed by 1H NMR (Supplementary Figure 6).

Data availability

All the data supporting the ﬁndings of this study are available within the Article
and its Supplementary Information ﬁle.
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